@FierceBiotech: Popular yesterday: 10 top drugs in biopharma's late-stage pipeline. Feature | Follow @FierceBiotech
@JohnCFierce: Few months after $60M C series and Forest deal, Trevena files for $86M IPO. SEC filing | Press release | Follow @JohnCFierce
@DamianFierce: MacroGenics has up-sized its IPO, now seeking $80M amid biotech blitz. ICYMI yesterday | Follow @DamianFierce
@EmilyMFierce: 3-D printing builds bacterial metropolises. More via ScienceNews | Follow @EmilyMFierce
> The FDA is putting Alkermes' ($ALKS) ALKS 5461 on the fast track. The biotech company is developing the drug for major depression. Release
> Singapore-based Aslan Pharmaceuticals has raised $22 million in a Series B. The biotech's model is to in-license preclinical therapies, take them through Phase II and then partner them out. Story
@FierceMedDev: Medtronic jumps into hemodialysis business through India partnership. ICYMI yesterday | Follow @FierceMedDev
@MarkHFierce: The head of Roche molecular diagnostics spoke to FierceDiagnostics recently about two key future products. More | Follow @MarkHFierce
@MichaelGFierce: Check out this week's FierceDrugDelivery newsletter! RNAi roundup & stem cell drug delivery action. Report | Follow @MichaelGFierce
> Are medical device companies invited to the biotech IPO party? Editor's corner
> Boston Scientific kicks off drug-eluting stent trial as sales wane. Story
> Quest warns reimbursement pressures, test volume declines will dampen Q3. More
> FDA panel casts doubt on CardioMEMS' heart failure diagnostic. Article
Pharma News
@FiercePharma: Top 10 Drugmakers in Emerging Markets--our latest special report. Feature | Follow @FiercePharma
@CarlyHFierce: Teva: Copying GlaxoSmithKline's Advair too tough for success before 2018. ICYMI yesterday | Follow @CarlyHFierce
> Which new drugs promise to shake up markets the most? Report
> Express Scripts stops covering key Big Pharma drugs on cost-effectiveness grounds. Story
> Teva plots 5,000 more job cuts in $2B savings drive. News
Pharma Manufacturing News
@EricPFierce: Will McKesson and AmerisourceBergen now face off in Europe? Article | Follow @EricPFierce
> Catalent moves on Brazil VMS, softgel market. News
> Vetter putting $100M into its production network. Report
> Teva looks for big savings from procurement, manufacturing. Story
> Feds fight drug imports Maine now allows. More
> BioCentury finds FDA has $270M in GDUFA, PDUFA fees in hand. Item
Vaccines News
> WHO prequalification moves China into global vaccine arena. Item
> Novartis opening vaccine R&D lab in North Carolina. Report
> Takeda's norovirus vaccine misses endpoint in early-phase trial. Story
> GSK targets 2015 launch for malaria vaccine. Article
> HIV trial follow-up quashes fears of infection risk. More
And Finally… Drawn to the dark side? You may be genetically predisposed. Release